摘要妊娠哺乳相关性骨质疏松症(pregnancy and lactationassociated osteoporosis,PLO)是一种特发性骨质疏松症,一般指妊娠晚期至产后18个月内,尤其产后/哺乳早期所诊断的骨质疏松,常因发生椎体脆性骨折而被发现,骨折部位常为下位胸椎及上位腰椎。PLO临床少见,发病机制尚未明确,1955年由Nordin等报道了第1例。因PLO发生在妊娠哺乳这一特殊时期,常导致孕产妇脊椎多发骨折,造成孕产妇生活能力下降,还会对胎儿和婴儿产生不良影响。本文报告1例PLO病例并进行文献复习,以引起临床医生的重视。
[1]何晓东,夏维波,邢小平,等.妊娠哺乳相关骨质疏松症临床分析[J].中华医学杂志,2009,89(14):983-985.
[2]Nordin BE,Roper A.Postpregnancy osteoporosis;a syndrome?[J].Lancet,1955,268(6861):431-434.
[3]刘洋贝,罗敏,马勋龙,等.妊娠哺乳相关骨质疏松症的诊治进展[J].中国骨质疏松杂志,2020,26(3):464-468.
[4]刘萍,王亚琴.妊娠哺乳相关骨质疏松症[J].世界最新医学信息文摘,2020,20(6):18-19.
[5]Kyvernitakis I,Reuter TC,Hellmeyer L,et al.Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up[J].Osteoporos Int,2018,29(1):135-142.
[6]Grizzo FMF,Janaina da SM,Marcelo MP,et al.Pregnancy and lactation-associated osteoporosis:Bone histomorphometric analysis and response to treatment with zoledronic acid[J].Calcif Tissue Int,2015,97(4):421-425.
[7]Kalliopi LA,George T,Ioannis PS,et al.Case report:Teriparatide treatment in a case of severe pregnancy-and lactation-associated osteoporosis[J].Hormones (Athens),2012,11(4):495.
[8]Kalkwarf HJ,Specker BL.Bone mineral changes during pregnancy and lactation[J].Endocrine,2002,17(1):49-53.
[9]Kovacs CS.Calcium and bone metabolism in pregnancy and lactation[J].J Clin Endocrinol Metab,2001,86(6):2344-2348.
[10]Kovacs CS,Ralston SH.Presentation and management of osteoporosis presenting in association with pregnancy or lactation[J].Osteoporosis International,2015,26(9):2223-2241.
[11]Kovacs CS.Calcium and bone metabolism during pregnancy and lactation[J].J Mammary Gland Biol Neoplasia,2005,10(2):105-118.
[12]Kovacs CS.Maternal mineral and bone metabolism during pregnancy,lactation,and post-Weaning recovery[J].Physiol Rev,2016,96(2):449-547.
[13]Kovacs CS.The skeleton is a storehouse of mMineral that is plundered during lactation and (fully?) replenished afterwards[J].J Bone Min Res,2017,32(4):676-680.
[14]Dunne F,Walters B,Marshall T,et al.Pregnancy associated osteoporosis[J].Clin Endocrinol (Oxf),1993,39(4):487-490.
[15]苏宏业,黄媛,李圣琦,等.妊娠哺乳相关骨质疏松症[J].中国骨质疏松杂志,2011,17(2):150-152.
[16]王诗玮,徐爱华,李玉姝.妊娠哺乳相关骨质疏松症一例[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(4):386-390.
[17]许琳,裴育.妊娠哺乳相关性骨质疏松症诊治[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(6):631-637.
[18]Li LJ,Zhang J,Gao P,Lv F,et al.Clinical characteristics and bisphosphonates treatment of rare pregnancy-and lactation-associated osteoporosis[J].Clin Rheumatol,2018,37(11):3141-3150.
[19]Laroche M,Talibart M.Pregnancy-related fractures:a retrospective study of a French cohort of 52 patients and review of the literature[J].Osteoporos Int,2017,28(11):3135-3142.
[20]Sefika BP,Berna E,Cevdet A,et al.Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide:case report and review of the literature[J].Gynecol Endocrinol,2015,31(7):522-525.
[21]Sánchez A,Zanchetta MB,Danilowicz K.Two cases of pregnancy-and lactation-associated osteoporosis successfully treated with denosumab[J].Clin Cases Miner Bone Metab,2016,13(3):244-246.
[22]Akifumi I,Hiromi Y,Ryoko A,et al.Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures:A case study[J].Taiwan J Obstet Gynecol,2017,56(6):863-866.